Trials / Recruiting
RecruitingNCT05380414
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
A Single-center, Prospective Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- Centre Leon Berard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The proposal is to implement a molecular screening program for advanced/metastatic pancreatic cancer patients before the initiation of 1st line treatment in order to allow a better selection of patients for rationale personalized medicine with targeted agents and/or combination involving a chemotherapy backbone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tumor samples (archival FFPE and optional de novo biopsy) and blood samples | Molecular screening |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2022-05-18
- Last updated
- 2026-03-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05380414. Inclusion in this directory is not an endorsement.